Company intelligence / Profile preview
MicroCures
Bronx, New York, United Statesmicrocures.com ↗
- Ownership
- Private
- Employees
- ~8
- Development stage
- Preclinical
01
Overview
MicroCures has demonstrated statistically significant improvement and acceleration of tissue repair in preclinical models across corneal, peripheral nerve, and dermal pathways. The company’s approach leverages local modulation of cell movement rather than systemic growth factors or stem cells. Clinical results are not yet available as the lead candidates are still in preclinical development.
- Therapeutic areas
- OncologyImmunologyOtherDermatologyCardiovascularOphthalmologyNeurology
- Modalities
- siRNA therapeuticsCell motility modulators
- Industry
- Biotech
02
Drug pipeline
3 assets2 more assets in the full pipeline.
Beyond the preview
Go deeper on MicroCures.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on MicroCures.